The Sequential Blood-based Biomarkers in Longitudinal Study of Alzheimer’s Disease and Mild Cognitive Impairment
博士 === 國立陽明大學 === 臨床醫學研究所 === 106 === Alzheimer’s disease (AD) is the most common neurodegenerative dementia. It is characterized by a progressive decline of cognition, behaviors and psychological symptoms (BPSD), and ultimately leads to total dependence. Mild cognitive impairment (MCI) is believed...
Main Authors: | Wei-Ju Lee, 李威儒 |
---|---|
Other Authors: | Shing-Jong Lin |
Format: | Others |
Language: | en_US |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/75dgyr |
Similar Items
-
Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
by: Te-Han Kung, et al.
Published: (2021-02-01) -
Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood‐based biomarkers
by: Cassandra A. DeMarshall, et al.
Published: (2016-01-01) -
Retinal blood flow in mild cognitive impairment and Alzheimer's disease
by: Gilbert T. Feke, et al.
Published: (2015-06-01) -
Neuroimage Biomarker Identification for Mild Cognitive Impairment to Alzheimer Disease Conversion
by: Te-HanKung, et al.
Published: (2018) -
Improved Diagnostic Multimodal Biomarkers for Alzheimer’s Disease and Mild Cognitive Impairment
by: Antonio Martínez-Torteya, et al.
Published: (2015-01-01)